Elanco agrees to divest brands to gain approval of US$7.6 billion acquisition of Bayer Animal Health

Elanco Animal Health has received regulatory approval of its acquisition of Bayer Animal Health after agreeing to several anti-trust related conditions. The US$7.6 billion deal was announced in August 2019. As part of its review, Canada’s Competition Bureau found Elanco and Bayer Animal Health are each other’s closest competitors in several markets, specifically in poultry insecticides… Read More

Leave a Reply

Your email address will not be published. Required fields are marked *